Company / Revenue
Cencora Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$321.3B
FY2025
5-year range
$179.6B / $321.3B
FY2021-FY2025
Trend
+9.3%
vs FY2024
Sector context
#3 of 155
Health Care
What the data says
Among 155 Health Care companies, Cencora is in the top 2% for revenue. Revenue has increased for 4 consecutive years, from $179.6B in FY2021 to $321.3B in FY2025.
Based on SEC 10-K filings.
$321.3B in FY2025 with a 5-year CAGR of +11.1%. Ranks 3rd among 155 companies in Health Care.
Improved from $214.0B to $321.3B over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +19.2%
- 5-Year CAGR
- +11.1%
- 10-Year CAGR
- -
Sector benchmark
Top 2% in Health CareTop 2% of 155This company $321.3B Sector average $19.1B
▼
+1582.6% above sector average
Key checks
Key Insights
- Cencora's revenue has grown for 4 consecutive years.
- 5-year CAGR of +11.1%, indicating consistent growth.
- In FY2025, revenue increased 9.3% year-over-year.
- Ranks #3 out of 155 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 4.32 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $321.3B | +9.3% |
| FY2024 | $294.0B | +37.4% |
| FY2023 | $214.0B | +12.7% |
| FY2022 | $189.9B | +5.7% |
| FY2021 | $179.6B | -5.4% |
| FY2020 | $189.9B | +5.7% |
| FY2019 | $179.6B | +6.9% |
| FY2018 | $167.9B | +9.7% |
| FY2017 | $153.1B | +4.3% |
| FY2016 | $146.8B | +8.0% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026